SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

$UPDOG is trending as the community rallies around the meme-based token on Solana, with many highlighting its longevity and strong holder base. Conversations frequently reference the humorous 'What's UpDog?' meme and the collaborative spirit with other communities like $BROKE and $WAGMI. The project emphasizes its community-driven nature, locked liquidity, and status as the only 'UpDog' on the $JUP Strict List.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI CRYPTO is currently trending due to community enthusiasm and anticipation, with many highlighting the "UpDog" meme. Discussions revolve around the shared goal of success, the power of community, and the potential for significant growth within the crypto space. The community is actively anticipating potential exchange listings.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending due to a recently announced $750 million offering, sparking discussions about dilution and the company's valuation; some community members are skeptical, labeling it a "scam," while others see potential in quantum computing and anticipate a "super spike," drawing comparisons to other quantum stocks like $IONQ and $RGTI. The community is actively debating whether the company's potential justifies its current valuation, especially given its revenue.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing ($RGTI) is trending as retail investors drive speculation in quantum computing stocks, leading to a massive surge despite concerns about the company's fundamentals and high valuation. The community is split between those expecting further gains and those anticipating a sharp correction, with some pointing to insider selling and potential dilution as red flags. Discussions also involve comparisons to other quantum computing companies and the broader tech sector.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid speculation of a potential partnership or investment from Tesla ($TSLA), fueled by social media activity and upcoming announcements. The community is actively discussing the potential implications of this collaboration, with some highlighting Archer's existing agreements and technology. Others caution against getting caught up in the hype, pointing to reports questioning Archer's progress and competitive landscape.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around a shared vision, emphasizing their commitment to building something lasting. The gaming aspect of earning $BROKE is a key talking point, with members actively engaging and expressing optimism for the future. There is also community cross-promotion with the tag $UPDOG

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as investors debate its high valuation relative to revenue, especially when compared to other quantum computing and tech companies like NVDA. Bullish sentiment is fueled by IONQ's collaborations, potential short squeeze, and a large after-hours buy order, while bears point to insider selling, lack of profitability, and potential for shareholder dilution. The stock's high price-to-sales ratio and the speculative nature of the quantum computing sector are also central to the conversation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending amid community discussion around recent trial data and its potential impact on the company's valuation. Despite mixed results from the VELA-2 trial, many believe the overall data supports the drug's efficacy and point to a buying opportunity, with some suggesting a potential buyout. The community is closely watching for further developments and speculating on potential price targets.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

Gold is trending as it reaches new all-time highs, driven by a weakening dollar and expectations of future Federal Reserve rate cuts. Community members are discussing the potential for further gains, citing ongoing economic and geopolitical uncertainty as factors that could continue to boost gold's value, while also noting technical indicators suggest it may be overbought.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is trending as community members highlight its strong community and potential for a significant rally, with some drawing parallels to previous meme coin successes. Discussions also mention Giga Fitness, a business selling merchandise to support the token, and speculate on potential price movements amid broader market trends. The community also talks about the most recent news and listing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates

Biodesix (BDSX) delivered earnings and revenue surprises of -14.29% and +7.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates

Avantor (AVTR) delivered earnings and revenue surprises of -4.00% and +0.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Biodesix Inc’s shares jumped Wednesday, driven by a sizable insider purchase and heightened retail investor optimism, even as Scotiabank cut its price target to $2 from $3 after the company reported weaker-than-expected first-quarter (Q1) revenue.The stock surged 45.9% to close at $0.4 on Wednesday, before falling 11.4% in after-hours trading to $0.35.Biodesix’s first-quarter revenue reached $17.96 million, below the analysts' anticipated $19.5 million consensus estimate.The lowered target also reflects a downward revision of the full-year 2025 revenue guidance amid a strategic commercial shift.Biodesix revised its 2025 revenue guidance to $80 million–$85 million, down from earlier forecasts.&nbsp;The company posted Q1 2025 revenue growth of 21% year-over-year, with diagnostic testing revenue rising 18% and development services revenue surging 61%.&nbsp;Gross margins improved to 79.4%, and net loss narrowed by 18%.&nbsp;CEO Scott Hutton said that a commercial pilot in late 2024 expanded outreach to pulmonologists and primary care physicians managing roughly half of lung nodule patients.&nbsp;After the pilot’s success, Biodesix restructured its sales team into a territory-based model across multiple specialties, delaying commercial expansion by about one quarter and contributing to the revised guidance.Despite the revenue miss and guidance cut, Biodesix reiterated expectations to achieve adjusted EBITDA positivity by Q4 2025, supported by strong gross margins and cost efficiencies.&nbsp;Over the past month, multiple research firms have lowered their price targets on Biodesix amid a challenging outlook.&nbsp;Notably, Canaccord cut its target twice — from $3.50 to $2.50 and further down to $1.50 — citing tariffs, funding uncertainty, and below-expectation Q1 results.&nbsp;Other firms,&nbsp;such as Lake Street and TD Cowen, lowered their targets to $2 following a Q1 revenue miss and salesforce restructuring.Craig-Hallum dropped its target to $1.50, anticipating further sell-offs, and William Blair downgraded the stock to ‘Market Perform’ due to slower sales-representative hiring and higher attrition.Meanwhile, the company said Tuesday that Jack W. Schuler, a 10% owner and director, executed a purchase of 4.7 million shares on May 16 for $1.3 million.&nbsp;Schuler previously served as&nbsp;president and&nbsp;chief operating officer of Abbott Laboratories before joining Ventana.&nbsp;Currently, Schuler controls 35.9 million common shares, all held indirectly.&nbsp;On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 510% surge in 24-hour message volume.One user urged investors to "trust the process" and maintain patience, citing Biodesix’s potential to meet compliance standards and reach profitability organically by year-end.&nbsp;<stembedurl>https://stocktwits.com/Trader1397/message/615454686</stembedurl>Meanwhile, others expressed optimism about Schuler’s recent sizable insider purchase, emphasizing his strong healthcare background and suggesting his stake could help spark renewed investor interest and upward momentum in the stock.<stembedurl>https://stocktwits.com/Babybillysbiblebonker/message/615448768</stembedurl>The stock has declined 73.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Biodesix logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut

Investors cheered a 4.7 million share insider purchase and rallied behind the company’s push toward Q4 EBITDA positivity, offsetting Scotiabank’s price target cut to $2 after a Q1 revenue miss and lowered 2025 guidance.

Equity

Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the third quarter ended September 30...

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be presented at the CHEST Annual Meeting 2024 in Boston...

Biodesix to Present at Two Investor Conferences in September

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that members of the Biodesix management team will present at two upcoming investor...

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that it will release financial results for the second quarter ended June 30, 2024 after the close of trading on...

Biodesix Named to Inc. Magazines 2024 Best Workplaces

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is honored to announce it has been named to Inc. Magazines Best Workplaces list. The ranking is a result of a comprehensive...

Biodesix to Participate in Two Investor Conferences in June

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor...

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$1.40	--	--	N/A
Q2 '25	-$0.07	-$1.60	-2216.59%	MISSED
Q1 '25	-$0.07	-$0.08	-14.64%	MISSED
Q4 '24	-$0.07	-$0.06	10.74%	BEAT
Q3 '24	-$0.07	-$0.07	4.28%	BEAT

BDSX
Biodesix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest BDSX News

BDSX Biodesix Inc